Continuing Advances in mBC: Optimizing CDK4&6 Inhibitor Treatment Outcomes
We are pleased to invite you for the next MBC TALKS webinar and live Q&A session where Prof. Eva Ciruelos, Prof. Marc Thill and Maria Noblet R.N. will discuss different CDK4&6i trials from an endocrine resistance perspective.
May 12th, 2021
12:00 – 13.00
Agenda
Optimizing CDK4&6 Inhibitor Treatment Outcomes – 20 min
Panel Discussion and live Q&A – 40 min
